mr 2034 has been researched along with naloxonazine in 2 studies
| Studies (mr 2034) | Trials (mr 2034) | Recent Studies (post-2010) (mr 2034) | Studies (naloxonazine) | Trials (naloxonazine) | Recent Studies (post-2010) (naloxonazine) |
|---|---|---|---|---|---|
| 48 | 0 | 0 | 200 | 0 | 30 |
| Protein | Taxonomy | mr 2034 (IC50) | naloxonazine (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Homo sapiens (human) | 0.0072 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.136 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.085 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rourke, JD; Shaw, JS | 1 |
| Johnson, N; Pasternak, GW | 1 |
2 other study(ies) available for mr 2034 and naloxonazine
| Article | Year |
|---|---|
Failure to demonstrate mu-isoreceptors.
Topics: Animals; Benzomorphans; Female; Mice; Naloxone; Nociceptors; Receptors, Opioid; Receptors, Opioid, mu; Respiration | 1984 |
The binding to rat brain homogenates of Mr2034, a universal opiate.
Topics: Animals; Benzomorphans; Brain; Cyclazocine; Dihydromorphine; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Ethylketocyclazocine; Male; Morphinans; Naloxone; Phenazocine; Rats; Rats, Inbred Strains; Receptors, Opioid | 1983 |